Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMassachusetts General Hospital

About this trial

The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to address the unmet need of preventing chronic emotional distress in YOD dyads through a feasible, acceptable and credible program, and ideally enhance resiliency and improve wellbeing and quality of life in both members of the dyad.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

40 years of age or older

Diagnosis of young-onset dementia (FTD, PPA, AD, PCA, etc.) with symptom onset prior to age 65 or evidence of familial AD onset up to age 70

Received YOD diagnosis in the past 10 months

English fluency and literacy

Disqualifiers

An additional, terminal diagnosis such as cancer

Unwillingness to participate and use zoom for video conferencing

Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use

Trial design

Design model

Parallel

Treatments tested in this trial

  • Resilient Together-YOD

    Behavioral

    This is a 6 session dyadic (patient and spousal care-partner) intervention that teaches resiliency and interpersonal communication skills early after YOD diagnoses. It aims to decrease heightened symptoms of depression and anxiety among dyads to help them engage in important decisions around long term care-planning and optimize adjustment. The goal is to equip dyads with the necessary skills to cope and engage in meaningful, challenging conversations around care-planning, symptom deterioration, work/family planning to improve well-being in both members of the dyad.

  • Health Enhancement Program-YOD

    Behavioral

    This is a 6 session program that will deliver educational information to dyads and will mimic the dose and duration of Resilient Together. The program will not teach any individual and dyadic interpersonal skills, but will contain education on psychological distress and healthy behaviors. Sessions will also be delivered virtually.

Treatment groups

388 Participants
are divided into 2 treatment groups
Group A: Experimental: Experimental Patient-Caregiver DyadsExperimental treatment 1 intervention
Group B: Control Patient-Caregiver DyadsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Emotional Distress

Hospital Depression and Anxiety Scale total score (HADS); 0-21 for each subscale (anxiety and depression), higher scores indicate greater anxiety or depression

Time frame
0 weeks, 6 weeks, 12 weeks

Secondary outcomes

1

Change in Resiliency Factors (Mindfulness)

Cognitive and Affective Mindfulness Scale (CAMS); 12-48, higher scores indicate greater perceived mindfulness

Time frame
0 weeks, 6 weeks, 12 weeks
2

Change in Resiliency Factors (Individual Coping)

Measure of Current Status Part A (MOCS-A) Assertiveness and Coping Confidence subscales; Subscale scores: 0-4; higher scores indicate greater perceived ability to cope

Time frame
0 week, 6 weeks, 12 weeks
3

Change in Resiliency Factors (Mindfulness Utilization)

Applied Mindfulness Scale (AMPS); 0-60, higher scores indicate greater use of mindfulness practices.

Time frame
0 weeks, 6 weeks, 12 weeks
4

Changes in Interpersonal Factors (Dyad Coping)

Dyadic Coping Inventory (DCI); 37-185, higher scores indicate greater perceived coping in the context of a relationship

Time frame
0 weeks, 6 weeks, 12 weeks

Other outcomes

1

Global Impressions of Change

Modified Global Impressions of Chance (MGIC); 1-7, higher scores indicate greater perceived change in outcomes

Time frame
6 weeks, 12 weeks
2

Cognition

Montreal Cognitive Assessment (MoCA); 0-30, lower scores indicate greater cognitive dysfunction

Time frame
0 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.